欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0861/001
药品名称SmofKabiven Perifer
活性成分
    • Tryptophan 0.63 g
    • Tyrosine 0.12 g
    • Valine 2.0 g
    • Alanine 4.4 g
    • Arginine 3.8 g
    • Calcium chloride 0.18 g
    • fish oil, rich in omega 3-acids 4.2 g
    • Glucose monohydrate 71.0 g
    • Glycine 3.5 g
    • Isoleucine 1.6 g
    • Lysine 2.1 g
    • Magnesium sulfate 0.38 g
    • medium-chain triglycerides 8.5 g
    • Methionine 1.3 g
    • OLIVE OIL monohydrate 7.0 g
    • Phenylalanine 1.6 g
    • Potassium chloride 1.4 g
    • Sodium glycerophosphate 1.3 g
    • Sodium acetate 1.1 g
    • SOYBEAN OIL monohydrate 8.5 g
    • Taurine 0.32 g
    • Threonine 1.4 g
    • Leucine 2.3 g
    • Histidine 0.93 g
    • Zinc sulfate 0.0 g
    • Serine 2.1 g
    • Proline 3.5 g
剂型Emulsion for infusion
上市许可持有人Fresenius Kabi AB 751 74 Uppsala Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      SmofKabiven peripher Emulsion zur Infusion
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Smofkabiven Peripheral
    • Latvia (LV)
    • Lithuania (LT)
      SmofKabiven Peripheral infuzinė emulsija
    • Estonia (EE)
    • Hungary (HU)
      SMOFKABIVEN PERIPHERAL emulziós infúzió
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
      Smofkabiven Peripheral, emulsie perfuzabila
    • Slovakia (SK)
    • Slovenia (SI)
许可日期2008/12/09
最近更新日期2025/02/07
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase